Ftse Mib
33.758,43
-1,27%
DAX
19.189,19
-0,16%
S&P 500
5.893,62
0,39%
NASDAQ
18.791,81
0,60%
Bitcoin
91.227,27
0,75%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kronos Bio Inc (KRON) Kronos Bio Inc (KRON) Notizie

Kronos Bio Inc

KRON
0,8499
-0,0001 (-0,01%)
19 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202422:02GLOBEKronos Bio Highlights Preclinical Data that Show p300 KAT..
13/11/202422:06EDGAR2Form 8-K - Current report
13/11/202422:05GLOBEKronos Bio Reports Third Quarter 2024 Financial Results and..
07/11/202422:47EDGAR2Form S-3 - Registration statement under Securities Act of..
05/11/202415:00GLOBEKronos Bio to Present Data at the ASH Annual Meeting from..
23/10/202414:55GLOBEKronos Bio Data Presentation at EORTC-NCI-AACR Symposium..
16/10/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202414:55GLOBEKronos Bio to Present Data at the EORTC-NCI-AACR Symposium..
07/10/202414:55GLOBEKronos Bio Announces Selection of Autoimmune Development..
25/9/202414:55GLOBEKronos Bio to Present Data at ACR Convergence 2024 to..
23/9/202414:55GLOBEKronos Bio Highlights Data at AACR Ovarian Cancer Research..
03/9/202414:55GLOBEKronos Bio Announces Participation in Medical and Investor..
08/8/202422:15GLOBEKronos Bio Reports Second Quarter 2024 Financial Results and..
08/8/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/7/202422:15GLOBEKronos Bio Announces First Patient Dosed with KB-0742 in an..
04/6/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/5/202423:15GLOBEKronos Bio to Present Clinical Update on Phase 1/2 Trial of..
22/5/202422:30GLOBEKronos Bio to Participate in Three Upcoming Healthcare..
21/5/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/5/202414:20EDGAR2Form 8-K - Current report
21/5/202414:15GLOBEKronos Bio Appoints Deborah Knobelman, Ph.D. as Chief..
09/5/202422:12EDGAR2Form 8-K - Current report
09/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:05GLOBEKronos Bio Reports First-Quarter 2024 Financial Results
24/4/202422:01GLOBEKronos Bio to Present Clinical Update on Phase 1/2 Trial of..
21/3/202412:05GLOBEKronos Bio Reports Recent Business Progress and..
07/3/202422:05EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEKronos Bio Announces Restructuring to Focus Resources on..
05/3/202422:44GLOBEKronos Bio To Present Three Posters at AACR 2024 Annual..
05/3/202413:00EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEKronos Bio Announces Participation in 44th Annual Cowen..
24/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/2/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/1/202414:05EDGAR2Form 8-K - Current report
06/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:06GLOBEKronos Bio Announces Pipeline Update and p300 KAT Inhibitor..
13/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBEKronos Bio Announces Participation in H.C. Wainwright 4th..
27/11/202322:05GLOBEKronos Bio Announces Participation in 35th Annual Piper..
Apertura: 0,855 Min: 0,845 Max: 0,8579
Chiusura: 0,85

La tua Cronologia

NASDAQ
KRON
Kronos Bio
BIT
F16971
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network